Amicus Therapeutics competitors

Amicus Therapeutics Competitors include Sanofi Genzyme, Mast Therapeutics, Zogenix and Clinigen Group.
Add company...
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Sanofi Genzyme
Sanofi Genzyme
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
Mast Therapeutics
Mast Therapeutics
A San Diego-based biopharmaceutical company.
Zogenix
Zogenix
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
Clinigen Group
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
Founding Date
Founding Date
2002
Founding Date
1981
Founding Date
1995
Founding Date
2006
Founding Date
2010
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cranbury Township, US HQ
Puteaux, FR
Munich, DE
Amsterdam, NL
Denham, GB
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Locations
Emeryville, US HQ
Windsor And Maidenhead, GB
Locations
Burton upon Trent, GB HQ
Employees
Employees
263
Employees
N/A
Employees
14133% increase
Employees
681% increase
Employees
465200% increase
Valuation ($)
Valuation ($)
2 b
Valuation ($)
N/A
Valuation ($)
358.7 m
Valuation ($)
1.7 b
Valuation ($)
1.8 b
Twitter followers
Twitter followers
793
Twitter followers
N/A
Twitter followers
873
Twitter followers
475
Twitter followers
1.2 k

Financial

Revenue (est.)
Revenue (est.)
$36.9m (FY, 2017)
Revenue (est.)
$5b (Y, 2017)
Revenue (est.)
N/A
Revenue (est.)
$9.8m (FY, 2017)
Revenue (est.)
£302.3m (FY, 2017)
Cost of goods
Cost of goods
$6.2m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$10.7m (FY, 2017)
Cost of goods
£179.6m (FY, 2017)
Gross profit
Gross profit
$30.7m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
($908k) (FY, 2017)
Gross profit
£122.7m (FY, 2017)
Net income
Net income
N/A
Net income
N/A
Net income
($29.8m) (FY, 2017)
Net income
($126.8m) (FY, 2017)
Net income
£3.8m (FY, 2017)

Operating

Countries
Countries
N/A
Countries
100 (Sep, 2018)
Countries
N/A
Countries
N/A
Countries
43 (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles

Sanofi Genzyme
HQ
Cambridge, US

Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.

View company
Mast Therapeutics
HQ
San Diego, US
Employees
14

A San Diego-based biopharmaceutical company.

View company
Zogenix
HQ
Emeryville, US
Employees
68↑ 1% increase

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.

View company
Clinigen Group
HQ
Burton upon Trent, GB
Employees
465

A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time

View company